- Home
- LTRY vs TOVX Comparison
LTRY vs TOVX Comparison
Compare LTRY & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- TOVX
- Stock Information
- Founded
- LTRY 2015
- TOVX 2001
- Country
- LTRY United States
- TOVX United States
- Employees
- LTRY N/A
- TOVX N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- LTRY Technology
- TOVX Health Care
- Exchange
- LTRY Nasdaq
- TOVX Nasdaq
- Market Cap
- LTRY 4.4M
- TOVX 4.7M
- IPO Year
- LTRY N/A
- TOVX 2006
- Fundamental
- Price
- LTRY $1.38
- TOVX $1.55
- Analyst Decision
- LTRY
- TOVX Strong Buy
- Analyst Count
- LTRY 0
- TOVX 1
- Target Price
- LTRY N/A
- TOVX $6.00
- AVG Volume (30 Days)
- LTRY 28.6M
- TOVX 136.3K
- Earning Date
- LTRY 04-02-2025
- TOVX 03-24-2025
- Dividend Yield
- LTRY N/A
- TOVX N/A
- EPS Growth
- LTRY N/A
- TOVX N/A
- EPS
- LTRY N/A
- TOVX N/A
- Revenue
- LTRY $6,143,350.00
- TOVX N/A
- Revenue This Year
- LTRY N/A
- TOVX N/A
- Revenue Next Year
- LTRY N/A
- TOVX N/A
- P/E Ratio
- LTRY N/A
- TOVX N/A
- Revenue Growth
- LTRY 190.77
- TOVX N/A
- 52 Week Low
- LTRY $0.22
- TOVX $1.14
- 52 Week High
- LTRY $2.82
- TOVX $17.00
- Technical
- Relative Strength Index (RSI)
- LTRY 57.11
- TOVX 52.70
- Support Level
- LTRY $1.29
- TOVX $1.54
- Resistance Level
- LTRY $2.04
- TOVX $1.75
- Average True Range (ATR)
- LTRY 0.45
- TOVX 0.13
- MACD
- LTRY 0.02
- TOVX 0.02
- Stochastic Oscillator
- LTRY 53.20
- TOVX 66.67
About LTRY Lottery.com Inc.
Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.